
-
Georgia ruling party wins local polls as mass protests flare
-
Depoortere stakes France claim as Bordeaux-Begles stumble past Lyon
-
Vinicius double helps Real Madrid beat Villarreal
-
New museum examines family life of Mexican artist Frida Kahlo
-
Piccioli sets new Balenciaga beat, with support from Meghan Markle
-
Lammens must be ready for 'massive' Man Utd scrutiny, says Amorim
-
Arteta 'not positive' after Odegaard sets unwanted injury record
-
Slot struggles to solve Liverpool problems after third successive loss
-
Netanyahu hopes to bring Gaza hostages home within days as negotiators head to Cairo
-
Ex-NFL QB Sanchez in hospital after reported stabbing
-
Liverpool lose again at Chelsea, Arsenal go top of Premier League
-
Liverpool suffer third successive loss as Estevao strikes late for Chelsea
-
Diaz dazzles early and Kane strikes again as Bayern beat Frankfurt
-
De Zerbi living his best life as Marseille go top of Ligue 1
-
US envoys head to Mideast as Trump warns Hamas against peace deal delay
-
In-form Inter sweep past Cremonese to join Serie A leaders
-
Kolisi hopes Rugby Championship success makes South Africa 'walk tall' again
-
Ex-All Black Nonu rolls back the years again as Toulon cruise past Pau
-
Hundreds of thousands turn out at pro-Palestinian marches in Europe
-
Vollering powers to European women's road race title
-
Struggling McLaren hit bump in the road on Singapore streets
-
'We were treated like animals', deported Gaza flotilla activists say
-
Czech billionaire ex-PM's party tops parliamentary vote
-
Trump enovys head to Egypt as Hamas agrees to free hostages
-
Arsenal go top of Premier League as Man Utd ease pressure on Amorim
-
Thousands attend banned Pride march in Hungarian city Pecs
-
Consent gives Morris and Prescott another memorable Arc weekend
-
Georgian police fire tear gas as protesters try to enter presidential palace
-
Vollering powers to European road race title
-
Reinach and Marx star as Springboks beat Argentina to retain Rugby Championship
-
Russell celebrates 'amazing' Singapore pole as McLarens struggle
-
Czech billionaire ex-PM's party leads in parliamentary vote
-
South Africa edge Argentina to retain Rugby Championship
-
'Everyone's older brother': Slipper bows out in Wallabies loss
-
Thousands rally in Georgia election-day protest
-
Sinner starts Shanghai defence in style as Zverev defies toe trouble
-
Russell takes pole position for Singapore Grand Prix as McLaren struggle
-
Robertson praises All Blacks 'grit' in Australia win
-
Government, protesters reach deal to end unrest in Pakistan's Kashmir
-
Kudus fires Spurs into second with win at Leeds
-
Rival rallies in Madagascar after deadly Gen Z protests
-
Egypt opens one of Valley of the Kings' largest tombs to public
-
Ethiopia hits back at 'false' Egyptian claims over mega-dam
-
Sinner breezes past Altmaier to launch Shanghai title defence
-
Czech ex-PM set to win vote, putting Ukraine aid in doubt
-
All Blacks down Wallabies to stay in Rugby Championship title hunt
-
Gazans hail Trump ceasefire call as Hamas agrees to free hostages
-
Zverev echoes Federer over tournaments 'favouring Sinner, Alcaraz'
-
Yamal injury complicated, return date uncertain: Barca coach Flick
-
Conservative Takaichi set to be Japan's first woman PM

Brazilian ritual root gets second life as potential anti-depressant
Long used in Indigenous Brazilian rituals, the jurema preta plant, which contains a potent psychedelic, is gaining ground as a potential treatment for depression.
At street stalls where medicinal herbs are sold, customers can buy the plant's root which contains dimethyltryptamine (DMT), a hallucinogenic substance that researchers say could be used to alleviate symptoms.
Following instructions he found on the internet, Guaracy Carvajal extracted DMT at home in 2016 from roots he bought on the street.
The 31-year-old software programmer, who had tried various treatment for chronic depression he has suffered since adolescence, said the drug makes it "feel like you've solved something in your life."
Physicist Draulio Araujo, who has conducted extensive research on the drug, said "the response is rapid. One day after treatment, (patients) already showed a significant improvement in their depression symptoms."
Yet he also warned that it "is not a magic cure" and that psychedelics "are not for everyone."
As a researcher at the Brain Institute of the Federal University of Rio Grande do Norte, Araujo and his team treated 14 people with the drug for six months.
The patients inhaled vaporized DMT, under medical supervision.
"It's common for our patients to say that something changed, that a key opened something," he said.
His patients also received psychological therapy, and some continued with conventional pharmaceutical drugs.
Neuroscientist Fernanda Palhano-Fontes, also of the Brain Institute, said "we have patients who improve significantly, others who don't improve at all."
Araujo's findings were published in the scientific journal Nature in April. In 2024, he published another study with promising results in the journal Psychedelic Medicine.
As for Carvajal, who stopped using jurema preta some time ago, he said the drug really allows a person to "start to have a lighter life."
It helped him get through a time when he was in "a state of questioning myself" about "work, day-to-day life," he said.
- Spiritual channels -
Brazil occupies a fairly prominent place in DMT research due to the substance's prominence in society, Araujo said.
While there is no ban on the cultivation or possession of jurema, which is also known as Mimosa tenuiflora, consumption of DMT is prohibited, except for religious and scientific use.
Jurema's roots are combined with other plants in a wine-like beverage that is consumed at rituals that include dancing and drums, part of Indigenous tradition in northeast Brazil where the plant grows.
"It's not hallucination," said Joyce Souza, a young woman attending a jurema ceremony in Planaltina, on the outskirts of Brasília.
"My spiritual channels become more accessible, I can communicate better with myself," Souza said.
Gathered in a house courtyard and dressed in white, the group of mostly novices waited for more seasoned practitioners to enter a trance and bring messages from ancient spirits.
Meanwhile, back in the lab, Araujo is hoping to expand his DMT research to a study of 100 patents.
"Let's say that in five years we'll have... a clear picture on when it will reach a real clinical setting," he said.
S.Gantenbein--VB